Showing results (1-10 of 10) with videos related to

Sort By:
Pageof 1
Innovative Surgical Sciences|October 16, 2023
Extracapsular extension of pN2 lymph node metastases is not prognostically significant in surgically resected patients with non-small cell lung cancerChristin Müller, Samantha Taber, Joachim Pfannschmidt, et al.
Journal of Thoracic Disease|September 28, 2019
Prognostic significance of the pattern of pathological N1 lymph node metastases for non-small cell lung cancerSergej Griff, Samantha Taber, Torsten T Bauer, et al.
The Thoracic and Cardiovascular Surgeon|February 18, 2021
Is Adjuvant Radiochemotherapy Always Mandatory in Patients with Resected N2 Non-Small Cell Lung Cancer?Samantha Taber, Joachim Pfannschmidt, Torsten T Bauer, et al.
Innovative Surgical Sciences|November 1, 2022
Value of 18F FDG-PET/CT parameters on long term follow-up for patients with non-small cell lung cancerMohammed Zoair, Samantha Taber, Roland Bittner, et al.
Case Reports in Pulmonology|June 26, 2023
Diffuse Alveolar Hemorrhage Associated with Epithelioid Angiosarcoma of the Lung: A Challenging DiagnosisFelix Wuest, Andreas Gebhardt, Claudia Grosswendt, et al.
Diagnostic Pathology|June 18, 2011
Morphometrical analysis of transbronchial cryobiopsiesSergej Griff, Wim Ammenwerth, Nicolas Schönfeld, et al.
BMC Pulmonary Medicine|November 5, 2014
Diagnostic yield of transbronchial cryobiopsy in non-neoplastic lung disease: a retrospective case seriesSergej Griff, Nicolas Schönfeld, Wilhelm Ammenwerth, et al.
Case Reports in Oncological Medicine|December 21, 2017
A Patient with Non-Hodgkin Lymphoma and Nonspecific Interstitial Pneumonia during Ibrutinib TherapySven Jungmann, Wolf-Dieter Ludwig, Nicolas Schönfeld, et al.
Cancer Management and Research|September 14, 2020
A Novel Epitope Quality-Based Immune Escape Mechanism Reveals Patient's Suitability for Immune Checkpoint InhibitionMichael Wessolly, Susann Stephan-Falkenau, Anna Streubel, et al.
Pageof 1